Merck and its partner Ridgeback Biotherapeutics announced on Monday that they’ve submitted an emergency authorization application to the US Food and Drug Administration (FDA) for their oral antiviral Covid treatment molnupiravir. The US-based pharmaceutical company revealed the request had been made to the FDA, with the hope that it will become the first authorized oral […]
